Publications

Our scientific output and findings

From groundbreaking discoveries in basic science to innovative clinical insights, our publications showcase the breadth and depth of research taking place at the UK DRI. 

Featured

man sitting on bed at night
- Research

Sleep problems could double risk of dementia in later life

People who experience sleep disorders are at greater risk of developing dementia and other neurodegenerative conditions later in life, new research led by Prof Valentina...

Learn more Sleep problems could double risk of dementia in later life
Computer methods and programs in biomedicine
Published

Shape matters: Predicting Huntington's disease using progression modelling

Authors
Mohsen Ghofrani-Jahromi, Susmita Saha, Adeel Razi, Pubu M Abeyasinghe, Govinda R Poudel, Jane S Paulsen, Sarah J Tabrizi, Nellie Georgiou-Karistianis
Shape matters: Predicting Huntington's disease using progression modelling
Nature reviews. Neurology
Published

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process

Authors
Harriet Demnitz-King, Sube Banerjee, Claudia Cooper, Charlotte Kenten, Rosemary Phillips, Sedigheh Zabihi, Yvonne Birks, Carol Brayne, Sallyann Browning, Camille Carroll, Georgina Charlesworth, Carol Ac Coupland, Tom Dening, Ruth Dobson, Isabelle F Foote, Sarah Foster, Chris Fox, Robert Howard, Jeremy D Isaacs, Uzma Jaffry, Ivan Koychev, Gill Livingston, David J Llewellyn, Richard Oakley, Magdalena Opazo Bretón, Martin Orrell, Alastair J Noyce, Tommy Pouncey, Greta Rait, Janice Ranson, Mohammed Rauf, Vanessa Raymont, Elizabeth L Sampson, Jonathan M Schott, Debs Smith, Xin You Tai, Alison Thomson, Sebastian Walsh, Dylan M Williams, Naaheed Mukadam, Charles R Marshall, National Institute of Health and Care Research Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London (DeNPRU-QM)
The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process
Alzheimer's research & therapy
Published

Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use

Authors
Heekyoung Kang, Yuna Gu, Jungah Lee, Soyeon Yoon, Henrik Zetterberg, Kaj Blennow, Fernando Gonzalez-Ortiz, Nicholas J Ashton, Theresa A Day, Michael W Weiner, Daeun Shin, Sohyun Yim, Seonghyeon Kim, Hee Kyung Park, Min Young Chun, Eun Hye Lee, Jun Pyo Kim, Hee Jin Kim, Duk L Na, Hyemin Jang, Sang Won Seo, ADNI and K-ROAD study group
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts

Authors
Derrek P Hibar, Alina Bauer, Christina Rabe, Niels Borlinghaus, Alexander Jethwa, Gwendlyn Kollmorgen, Annunziata Di Domenico, Henrik Zetterberg, Kaj Blennow, Colin L Masters, Reisa A Sperling, Tobias Bittner
Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts
Psychological medicine
Published

Subjective estimation of cognitive function in mild cognitive impairment: relationship with neurodegenerative and non-degenerative factors

Authors
Calum A Hamilton, Peter Gallagher, Paul C Donaghy, Joanna Ciafone, Michael Firbank, Gemma Greenfinch, Amanda Heslegrave, Henrik Zetterberg, John-Paul Taylor, Louise M Allan, John T O'Brien, Alan J Thomas
Subjective estimation of cognitive function in mild cognitive impairment: relationship with neurodegenerative and non-degenerative factors
Alzheimer's & dementia (New York, N. Y.)
Published

Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's disease

Authors
Philip Scheltens, Alireza Atri, Howard H Feldman, Henrik Zetterberg, Mary Sano, Peter Johannsen, Teresa León Colombo, Lars Bardtrum, Rose Jeppesen, Charlotte T Hansen, Jeffrey L Cummings
Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of semaglutide in participants with early-stage symptomatic Alzheimer's disease
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Biomarkers

Authors
Julie E Oomens, Theresa M Harrison, Jeffrey L Dage, Kristen A Russ, Henrik Zetterberg, William J Jagust, Tatiana M Foroud, Sarah Biber, Elizabeth C Mormino, Sterling C Johnson
Biomarkers
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Biomarkers

Authors
Jakub Vávra, Wiebke Traichel, Andrea Benedet, Hanna Huber, Kaj Blennow, Laia Montoliu-Gaya, Nicholas Ashton, Henrik Zetterberg
Biomarkers
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Biomarkers

Authors
Annalise E Miner, Nicholas J Ashton, Henrik Zetterberg, Kaj Blennow, Jenna R Groh, Yorghos Tripodis, Charles Adler, Laura Balcer, Charles B Bernick, Elaine R Peskind, Breton M Asken, Jeremy A Tanner, Gil D Rabinovici, Sarah J Banks, William B Barr, Jennifer V Wethe, Robert C Cantu, David W Dodick, Jesse Mez, Joseph N Palmisano, Brett Martin, Thor D Stein, Ann C McKee, Jeffrey L Cummings, Martha E Shenton, Eric M Reiman, Robert A Stern, Michael L Alosco
Biomarkers
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Biomarkers

Authors
Magdalena A Kolanko, Raphaella Jackson, Eyal Soreq, Michael Cb David, Kirsten Jensen, Amanda J Heslegrave, Martin Tran, Michael Crone, Sarah Daniels, David Wingfield, Henrik Zetterberg, Paul Freemont, David J Sharp
Biomarkers
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published

Biomarkers

Authors
Aitana Sogorb-Esteve, Sophia Weiner, Joel Simrén, Imogen J Swift, Kaj Blennow, Henrik Zetterberg, Jonathan D Rohrer, Johan Gobom
Biomarkers